Skip to main content
Log in

H. pylori and Functional Dyspepsia

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The relationship between H. pylori and functional dyspepsia is controversial. Hypothesizing that subjects with a more intense immune response to H. pylori (and hence higher antibody titers) would be at greater risk of dyspepsia, we aimed to identify risk factors for the development of dyspeptic symptoms. In all, 491 healthy blood donors with no history of peptic ulceration and 74 consecutive patients with a confirmed diagnosis of functional dyspepsia were studied. Symptoms and potential risk factors [nonsteroidal antiinflammatory drugs (NSAIDs), alcohol, and smoking] were measured by a validated questionnaire. H. pylori status was determined by IgG antibodies using a validated ELISA test with a cutoff titer for a positive serology of 10 units/ml. Logistic regression analysis assessed the association between risk factors and dyspepsia. Among blood donors, 21% (95% CI 17.6–24.8) reported dyspepsia (pain localized to the upper abdomen); 7.7% (95% CI 5.5–10.4) had frequent dyspepsia (>6 times in the prior year). The age-adjusted prevalence of H. pylori was not significantly different in blood donors with (39.5%, 95% CI 24.0–56.6) and without frequent dyspepsia (34.2%, 95% CI 29.8–38.36), but was significantly greater in patients with functional dyspepsia (68.8%, 95% CI 57.3–77.9). In the combined study population of blood donors and patients with functional dyspepsia, logistic regression adjusting for age identified the following independent risk factors for frequent dyspepsia: high serum antibody levels against H. pylori (OR for IgG titer >50 units/ml vs H. pylori titers 11–50 units/ml 4.6, 95% CI 2.7–7.8) and consumption of standard NSAIDs (OR 2.4, 95% CI 1.3–4.5). In contrast, alcohol (OR 0.6, 95% CI 0.3–1.0), smoking (OR 1.5, 95% CI 1.0–2.3) or positive H. pylori serology with titers ≤50 units/ml (OR 1.6, 95% CI 0.8–2.9) were not associated with frequent dyspepsia. In conclusion, in a subgroup of H. pylori-infected subjects who have high antibody titers, H. pylori appears to be associated with functional dyspepsia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Colin-Jones DG, Bloom B, Bodemar G, Crean G, Freston J, Gugler R, Malagelada J, Nyrén O, Petersen H, Piper D: Management of dyspepsia: Report of a working party. Lancet 1:576–579, 1988

    Google Scholar 

  2. Rauws EA, Langenberg W, Houthoff HJ, Zanen HC, Tytgat GN: Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 94:33–40, 1988

    Google Scholar 

  3. Lambert JR, Dunn K, Borromeo M, Korman MG, Hansky J: Campylobacter pylori–a role in non-ulcer dyspepsia? Scand J Gastroenterol Suppl 160:7–13, 1989

    Google Scholar 

  4. Rokkas T, Pursey C, Uzoechina E, Dorrington L, Simmons NA, Filipe MI, Sladen GE: Campylobacter pylori and non-ulcer dyspepsia. Am J Gastroenterol 82:1149–1152, 1987

    Google Scholar 

  5. Greenberg RE, Bank S: The prevalence of Helicobacter pylori in nonulcer dyspepsia. Arch Intern Med 150:2053–2055, 1990

    Google Scholar 

  6. O'Morain C, Gilvarry J: Eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. Scand J Gastroenterol Suppl 28:30–33, 1993

    Google Scholar 

  7. Vaira D, Holton J, Ainley C, Falzon M, Osborn J, D'Anna L, Romanos A, Chandrakumaran K, McNeil I: Double blind trial of colloidal bismuth subcitrate versus placebo in Helicobacter pylori positive patients with non-ulcer dyspepsia. Ital J Gastroenterol 24:400–404, 1992

    Google Scholar 

  8. Talley NJ: A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia. Gastroenterology 106:1174–1183, 1994

    Google Scholar 

  9. Marshall BJ: Virulence and pathogenicity of Helicobacter pylori. J Gastroenterol Hepatol 6:121–124, 1991

    Google Scholar 

  10. Wyatt JI, Rathbone BJ, Heatley RV: Local immune response to gastric Campylobacter in non-ulcer dyspepsia. J Clin Pathol 39:863–870, 1986

    Google Scholar 

  11. Rathbone BJ, Wyatt JI, Worsley BW, Shires SE, Trejdosiewicz LK, Heatley RV, Losowsky MS: Systemic and local antibody responses to gastric Campylobacter pyloridis in non-ulcer dyspepsia. Gut 27:642–647, 1986

    Google Scholar 

  12. Talley NJ, McNeil D, Piper DW: Environmental factors and chronic unexplained dyspepsia. Association with acetaminophen but not other analgesics, alcohol, coffee, tea, or smoking. Dig Dis Sci 33:641–648, 1988

    Google Scholar 

  13. Talley NJ, Evans JM, Fleming KC, Harmsen WS, Zinsmeister AR, Melton LJ: Nonsteroidal antiinflammatory drugs and dyspepsia in the elderly. Dig Dis Sci 40:1345–1350, 1995

    Google Scholar 

  14. Holtmann G, Goebell H, Holtmann M, Talley NJ: Dyspepsia in healthy blood donors: Pattern of symptoms and association with Helicobacter pylori Dig Dis Sci 39:1090–1098, 1994

    Google Scholar 

  15. Blaser MJ, Duncan DJ: Human serum antibody response to Campylobacter jejuni infection as measured in an enzyme linked immunoabsorbent assay. Infect Immun 33:292–298, 1984

    Google Scholar 

  16. Talley NJ, Newell DG, Ormand JE, Carpenter HA, Wilson WR, Zinsmeister AR, Perez-Perez GI, Blaser MJ: Serodiagnosis of Helicobacter pylori: Comparison of enzyme-linked immunosorbent assay. J Clin Microbiol 29:1635–1639, 1991

    Google Scholar 

  17. Talley NJ, Phillips SF, Melton LJI, Wiltgen C, Zinsmeister AR: A patient questionnaire to identify bowel disease. Ann Intern Med 111:671–674, 1989

    Google Scholar 

  18. Holtmann G, Goebell H, Talley NJ: Dyspepsia in consulters and nonconsulters: Prevalence, health-care seeking behaviour and risk factors. Eur J Gastroenterol Hepatol 6:917–924, 1994

    Google Scholar 

  19. Locke GR, Talley NJ, Weaver AL, Zinsmeister AR: The fluctuating course of functional bowel disease: A four-year community study. Gastroenterology 106:A16, 1994

    Google Scholar 

  20. Talley NJ, Zinsmeister AR, Schleck CD, Melton LJI, Melton LJ: Smoking, alcohol and analgesics in dyspepsia and among dyspepsia subgroups: Lack of an association in the community. Gut 35:619–624, 1994

    Google Scholar 

  21. Talley NJ, Weaver AL, Tesmer DL, Zinsmeister AR: Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology 105:1378–1386, 1993

    Google Scholar 

  22. Talley NJ, Zinsmeister AR, Schleck CD, Melton LJI: Dyspepsia and dyspepsia subgroups: A population-based study. Gastroenterology 102:1259–1268, 1992

    Google Scholar 

  23. Talley NJ, Colin-Jones D, Koch KL, Koch M, Nyrén O, Stanghellini V: Functional dyspepsia: A classification with guidelines for diagnosis and management. Gastroenterol Int 4:145–160, 1991

    Google Scholar 

  24. Thompson WG, Heaton KW: Functional bowel disorders in apparently healthy people. Gastroenterology 79:283–288, 1980

    Google Scholar 

  25. Gardner M, Altman DG: Calculating confidence intervals for proportions and their differences. In Statistics with Confidence–Confidence Intervals and Statistical Guidelines. M Gardner, DG Altman (eds). BMJ-Group, London, 1991, pp 28–33

    Google Scholar 

  26. SAS Institute Inc: SAS/STAT User's Guide, Release 6.03. Cary, North Carolina, SAS Institute Inc., 1988

    Google Scholar 

  27. Talley NJ, Janssens J, Lauritsen K, Racz I, Bolling-Sternevald E: Eradication of Helicobacter pylori in functional dyspepsia: Randomised double blind placebo controlled trial with 12 months' follow up. The optimal regimen cures Helicobacter-Induced Dyspepsia (ORCHID) Study Group. BMJ 318:833–837, 1999

    Google Scholar 

  28. Blum AL, Talley NJ, O'Morain C, Van Zanten SV, Labenz J, Stolte M, Louw JA, Stubberod A, Theodors A, Sundin M, Bolling-Sternevald E, Junghard O: Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. N Engl J Med 339:1875–1881, 1998

    Google Scholar 

  29. Talley NJ, Vakil N, Ballard II D, Fennerty MB: Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. N Engl J Med 341:1106–1111, 1999

    Google Scholar 

  30. McColl K, Murray L, El-Omar E, Dickson A, El-Nujumi A, Wirz A, Kelman A, Penny C, Knill-Jones RP, Hilditch T: Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med 339:1869–1874, 1998

    Google Scholar 

  31. Phadnis SH, Ilver D, Janzon L, Normark S, Westblom TU: Pathological significance and molecular characterization of the vacuolating toxin gene of Helicobacter pylori. Infect Immun 62:1557–1565, 1994

    Google Scholar 

  32. Cover TL, Cao P, Murthy UK, Sipple MS, Blaser MJ: Serum neutralizing antibody response to the vacuolating cytotoxin of Helicobacter pylori. J Clin Invest 90:913–918, 1992

    Google Scholar 

  33. Holtmann G, Talley NJ, Mitchell H, Hazell S: Antibody response to specific H. pylori antigens in functional dyspepsia, duodenal ulcer disease, and health. Am J Gastoenterol 93:1222–1227, 1998

    Google Scholar 

  34. Malagelada JR, Stanghellini V: Manometric evaluation of functional upper gut symptoms. Gastroenterology 88:1223–1231, 1985

    Google Scholar 

  35. Lemann M, Dederding JP, Flourie B, Franchisseur C, Rambaud JC, Jian R: Abnormal perception of visceral pain in response to gastric distension in chronic idiopathic dyspepsia. The irritable stomach syndrome. Dig Dis Sci 36:1249–1254, 1991

    Google Scholar 

  36. Bradette M, Pare P, Douville P, Morin A: Visceral perception in health and functional dyspepsia. Crossover study of gastric distension with placebo and domperidone. Dig Dis Sci 36:52–58, 1991

    Google Scholar 

  37. Kellow JE, Eckersley CM, Jones MP: Enhanced perception of physiological intestinal motility in the irritable bowel syndrome. Gastroenterology 101:1621–1627, 1991

    Google Scholar 

  38. Holtmann G, Goebell H, Talley NJ: Impaired small intestinal peristaltic reflexes and sensory thresholds are independent functional disturbances in patients with chronic unexplained dyspepsia. Am J Gastroenterol 91:485–491, 1996

    Google Scholar 

  39. Mearin F, DeRibot X, Balboa A, Salas A, Varas MJ, Cucala M, Bartolomé R, Armengol JR, Malagelada JR: Does Helicobacter pylori infection increase gastric sensitivity in functional dyspepsia? Gut 37:47–51, 1995

    Google Scholar 

  40. Holtmann G, Talley NJ, Goebell H: Association between H. pylori, duodenal mechanosensory thresholds and small intestinal motility in chronic unexplained dyspepsia. Dig Dis Sci 41:1285–1291, 1996

    Google Scholar 

  41. Gschossmann J, Holtmann G, Bünger L, Gerken G: Long term effects of an acute chemically induced colitis on the visceromotor response to mechanical colorectal distension. Gastroenterology 2000 (in press)

  42. Vaira D, Miglioli M, Mule P, Holton J, Menegatti M, Vergura M, Biasco G, Conte R, Logan RPH, Barbara L: Prevalence of peptic ulcer in Helicobacter pylori positive blood donors. Gut 35:309–312, 1994

    Google Scholar 

  43. Anand BS, Malaty H, Genta RM, Graham DY: Peptic ulcer is rare in asymptomatic adults with Helicobacter pylori infection. Gut 37:A10, 1995

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Holtmann, G., Gschossmann, J., Holtmann, M. et al. H. pylori and Functional Dyspepsia. Dig Dis Sci 46, 1550–1557 (2001). https://doi.org/10.1023/A:1010612509593

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1010612509593

Navigation